Back to basics: How to build a portfolio
Figuring out which funds to buy is overwhelming for even the most experienced investors – but as a beginner, it’s important to understand yo...
Radio and PodcastLive Radio & Podcasts
Business
Investors Chronicle
Concerned with QE's effects on equity valuations? Looking for ideas for your Isa? Or just plain confused by the stock market? Each week, the Investors Chronicle picks apart the latest news f...
Episodes
20 of 1,177 episodes
Semiconductor stocks, our Top 50 Funds and Mortgage Advice Bureau: Companies and Markets Show
Even as uncertainty reins in the markets, 2026 has been another bumper year for returns. But, as ever, that does hide plenty of dispersion b...
Our favourite ETFs, toxic stocks to avoid and industrials: Companies and Markets show
This week’s show begins with a look at Meta after the social media giant had to fork out $18bn following accusations that its products are d...
Protecting your pension, UK industrials and Nvidia: Companies and Markets Show
First, we cast our ears to British industrial stocks and ask whether they are being picked off too cheaply. Michael Fahy dives into why manu...
How to invest under Andy Burnham: Lee and the IC
After a summer hiatus, Alex Newman and Lord Lee are back in the studio, and the duo have a lot to catch up on. The UK has seen a change of p...
JD Sports, Pershing Square’s overhaul and Oxford Nanopore:Companies and Markets Show
Up first this week is self-labelled ‘King of Trainers’ JD Sports, whose shares took a 15 per cent tumble on Thursday morning. The FTSE 100 r...
Legal & General, infrastructure stocks and GSK: Companies and Markets Show
After an avalanche of earnings updates, we turn to our annual Income Majors special report and dive into two prominent FTSE 100 dividend sto...
How to defeat the gender wealth gap
Women, on average, earn less than men, have less saved in a pension and have to take more time off from work to care for others. But while s...
The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show
M&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US r...
US IPOs, Rentokil and emerging markets: Companies and Markets show
Results season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards,...
‘We are the space 3i’: Mark Boggett of Seraphim Space
Seraphim Space (SSIT) has been one of the best performing investment trusts in the past year. Helped by the enthusiasm for the sector genera...
Terry Smith, construction stocks and Mony Group:Companies and Markets Show
As the half-year results season falls upon us, a smorgasbord of companies are reporting over the next few weeks. But today’s episode focuses...
AI inflation, defence stocks and India funds: Companies and Markets Show
This week begins with how booming demand for AI infrastructure is driving a sharp increase in the price of memory chips. Erin Withey is in t...
Labour’s social media plans, house prices and legal stocks: Companies and Markets Show
This week’s show begins with Labour’s decision to force tech giants to give more prominence to traditional news broadcasters on social media...
What is the gender health gap – and how to beat it
The gender health gap is an issue which affects far more than just wellbeing; it impacts your career, earnings and long-term financial stabi...
AI vs recruiters, another IPO and farming stocks
In this week’s episode, we turn to Britain’s recruitment stocks. Valeria Martinez looks at the impact of AI on hiring demand, which is hitti...
Ocado, asset managers and Telecom Plus: Companies and Markets Show
This week, we begin with online grocer Ocado (OCDO) following reports of a CEO switch. Julian Hofmann dives into what a potential change at...
AO World, wealth managers & Castings: The Companies and Markets Show
This week, we begin proceedings with a look at the contrasting fortunes of two UK wealth managers: Aim-traded Tatton Asset Management (TAM)...
Meeting with Fevara’s CEO: Lee and the IC
Fevara (FVA:127p) may be new in name, but its roots and expertise stretch back more than a century through the former Carr’s Group. In the w...
Investing in photonics, GSK and new opportunities in venture capital: Companies and Markets Show
This week’s show dives straight into safety and equipment maker Halma (HLMA) , which reported its full-year results on Thursday morning. It...